eXCELL Biotech is Paving the Way for Transformative Cancer Treatment at Meet Taipei 2025

We are thrilled to be participating in the 2025 Meet Taipei Startup Festival, showcasing how strategic Patent Innovation is accelerating the future of medicine!

At the heart of our exhibit is our groundbreaking xenogeneic cell cancer immunotherapy. We’re leveraging the body’s natural immune response to non-self cells to develop a powerful, constructive new treatment modality for difficult-to-treat cancers and other intractable diseases.

This proprietary platform, protected by our growing portfolio of global patents, demonstrates our commitment to transforming patient outcomes. We believe the future of cellular medicine is here—and it’s driven by IP.

Join us at the NEXT IS NOW: Patent Driven, Global View special zone to explore how our innovations are moving from lab to clinic. Let’s build a healthier world, together.